AceLink is advancing a small-molecule treatment option for Fabry disease, which could provide a more convenient alternative to the current enzyme replacement therapy standard.
AceLink is advancing a small-molecule treatment option for Fabry disease, which could provide a more convenient alternative to the current enzyme replacement therapy standard.